Literature DB >> 31165706

The Effect of FERMT1 Regulated by miR-24 on the Growth and Radiation Resistance of Esophageal Cancer.

Qihang Yan, Tao Chen, Han Yang, Hui Yu, Yuzhen Zheng, Tiancheng He, Junye Wang.   

Abstract

The present study addresses the role and underlying mechanism of FERMT1 in the development of esophageal cancer (EC). High level of FERMT1 expression was found in human EC tissues and was significantly correlated with poor overall survival. Overexpression of FERMT1 by a lentiviral vector markedly promoted EC cell proliferation and radiation resistance in vitro and facilitated tumor growth in vivo. Using the luciferase assay, we further documented that microRNA-24 (miR-24) suppressed the expression of FERMT1 through direct binding to the 3 -untranslated region (3 -UTR) of its mRNA. While forced miR-24 expression suppressed cell growth and enhanced the radiosensitivity of EC cells, re-expression of FERMT1 reversed these effects. Together, our data indicate that FERMT1 acts as an oncogene and is negatively regulated by miR-24, supporting the potential therapeutic strategy against esophageal cancer by targeting miR-24-FERMT1 axis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31165706     DOI: 10.1166/jbn.2019.2711

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  7 in total

Review 1.  The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma.

Authors:  Hongfang Zhang; Jingxing Si; Jing Yue; Shenglin Ma
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-09       Impact factor: 4.553

Review 2.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.

Authors:  Sandra Roche; Fiona O'Neill; Jean Murphy; Niall Swan; Justine Meiller; Neil T Conlon; Justin Geoghegan; Kevin Conlon; Ray McDermott; Rozana Rahman; Sinead Toomey; Ninfa L Straubinger; Robert M Straubinger; Robert O'Connor; Gerard McVey; Michael Moriarty; Martin Clynes
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

4.  FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis.

Authors:  Hua Fan; Shengjun Zhang; Yu Zhang; Wu Liang; Bo Cao
Journal:  Cancer Biol Ther       Date:  2020-07-29       Impact factor: 4.742

5.  FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial-mesenchymal transition and cell cycle arrest.

Authors:  Lingling Li; Piao Li; Wei Zhang; Haiting Zhou; Ergang Guo; Guoqing Hu; Linli Zhang
Journal:  Cancer Cell Int       Date:  2022-02-10       Impact factor: 5.722

6.  Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma.

Authors:  Lingyan Xiao; Qian Li; Yongbiao Huang; Zhijie Fan; Wan Qin; Bo Liu; Xianglin Yuan
Journal:  Front Cell Dev Biol       Date:  2022-04-26

7.  MiR-24-3p as a prognostic indicator for multiple cancers: from a meta-analysis view.

Authors:  He Wang; Chunyang Chen; Keke Ding; Weijie Zhang; Jianquan Hou
Journal:  Biosci Rep       Date:  2020-12-23       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.